Natco Pharma is scouring for acquisitions in the US and Rest of the World (RoW) markets, according to its Vice-Chairman and Chief Executive Officer, Rajeev Nannapaneni. “We are working on it ...

In the face of looming revenue decline from blood cancer medication Revlimid, Indian pharma companies Natco Pharma and Dr. Reddy's Laboratories are shifting their focus to a promising new frontier ...

“Need to buy a front-end manufacturing [facility] in the U.S. That’s the only way you can go forward,” Natco Pharma’s vice-chairman and CEO Rajeev Nannapaneni said replying to a query ...

NATCO Pharma Share Price: NATCO Pharma shares on Thursday crashed 20 per cent to hit the lower circuit after poor Q3 results FY2025. NATCO Pharma shared opened gap down with a cur of nearly 14 per ...

Mankind Pharma, India’s fourth largest drugmaker by domestic sales, is setting its sights on anti-obesity drugs like Semaglutide, better known by brand names Ozempic and Wegovy, which goes off ...

Drugmaker Eli Lilly plans to build four new manufacturing plants in the U.S., a $27 billion investment that the company expects will create 3,000 high-skilled jobs and employ 10,000 construction ...